JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2002; 40:1609-1614
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehra, M. R.
Right arrow Articles by Lavie, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehra, M. R.
Right arrow Articles by Lavie, C. J.

Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival

Mandeep R. Mehra, MD, FACC*,*, Patricia A. Uber, PharmD*, Krishnamoorthy Vivekananthan, MD*, Sergio Solis, MD*, Robert L. Scott, MD, FACC*, Myung H. Park, MD*, Richard V. Milani, MD, FACC* and Carl J. Lavie, MD, FACC*

* Ochsner Clinic Foundation, New Orleans, Louisiana, USA



View larger version (13K):

[in a new window]
  		Figure 1 Rates of allograft rejection (%) between pravastatin (black bars) and simvastatin (white bars). HDC = hemodynamic compromise.

 


View larger version (13K):

[in a new window]
  		Figure 2 Comparison of average biopsy rejection scores. *p < 0.05 for simvastatin or pravastatin group compared with statin-naive groups.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.